ScoreWhy is Cosmos Health, Inc. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 5.28% over the last 5 years
- The company is Net-Debt Free
- The company has reported losses. Due to this company has reported negative ROE
2
Negative results in Mar 26
- NET PROFIT(HY) At USD -15.11 MM has Grown at -49.97%
- INTEREST(HY) At USD 1.83 MM has Grown at 260.36%
- RAW MATERIAL COST(Y) Grown by 59% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -50.05%, its profits have risen by 32.9%
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -50.05% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Cosmos Health, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Cosmos Health, Inc.
-50.05%
-0.65
102.67%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.28%
EBIT Growth (5y)
-251.75%
EBIT to Interest (avg)
-7.46
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.45
Sales to Capital Employed (avg)
1.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.40%
ROCE (avg)
1.92%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.53
EV to EBIT
-2.33
EV to EBITDA
-2.60
EV to Capital Employed
0.74
EV to Sales
0.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-31.81%
ROE (Latest)
-67.64%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(HY)
At USD 37.63 MM has Grown at 34.7%
NET PROFIT(HY)
Higher at USD -15.11 MM
PRE-TAX PROFIT(Q)
At USD -2.82 MM has Grown at 39.54%
-17What is not working for the Company
NET PROFIT(HY)
At USD -15.11 MM has Grown at -49.97%
INTEREST(HY)
At USD 1.83 MM has Grown at 260.36%
RAW MATERIAL COST(Y)
Grown by 59% (YoY
Here's what is working for Cosmos Health, Inc.
Net Sales
At USD 37.63 MM has Grown at 34.7%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (USD MM)
Net Profit
Higher at USD -15.11 MM
than preceding 12 month period ended Mar 2026MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Pre-Tax Profit
At USD -2.82 MM has Grown at 39.54%
over average net sales of the previous four periods of USD -4.67 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Here's what is not working for Cosmos Health, Inc.
Net Profit
At USD -15.11 MM has Grown at -49.97%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Interest
At USD 1.83 MM has Grown at 260.36%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Raw Material Cost
Grown by 59% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
